326 related articles for article (PubMed ID: 30532261)
1. Predicting protein targets for drug-like compounds using transcriptomics.
Pabon NA; Xia Y; Estabrooks SK; Ye Z; Herbrand AK; Süß E; Biondi RM; Assimon VA; Gestwicki JE; Brodsky JL; Camacho CJ; Bar-Joseph Z
PLoS Comput Biol; 2018 Dec; 14(12):e1006651. PubMed ID: 30532261
[TBL] [Abstract][Full Text] [Related]
2. Predicting kinase inhibitors using bioactivity matrix derived informer sets.
Zhang H; Ericksen SS; Lee CP; Ananiev GE; Wlodarchak N; Yu P; Mitchell JC; Gitter A; Wright SJ; Hoffmann FM; Wildman SA; Newton MA
PLoS Comput Biol; 2019 Aug; 15(8):e1006813. PubMed ID: 31381559
[TBL] [Abstract][Full Text] [Related]
3. A computational approach to finding novel targets for existing drugs.
Li YY; An J; Jones SJ
PLoS Comput Biol; 2011 Sep; 7(9):e1002139. PubMed ID: 21909252
[TBL] [Abstract][Full Text] [Related]
4. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
5. Protein domain-based prediction of drug/compound-target interactions and experimental validation on LIM kinases.
Doğan T; Akhan Güzelcan E; Baumann M; Koyas A; Atas H; Baxendale IR; Martin M; Cetin-Atalay R
PLoS Comput Biol; 2021 Nov; 17(11):e1009171. PubMed ID: 34843456
[TBL] [Abstract][Full Text] [Related]
6. Identifying Drug-Target Interactions with Decision Templates.
Yan XY; Zhang SW
Curr Protein Pept Sci; 2018; 19(5):498-506. PubMed ID: 27829344
[TBL] [Abstract][Full Text] [Related]
7. The Use of Large-Scale Chemically-Induced Transcriptome Data Acquired from LINCS to Study Small Molecules.
Iwata M; Yamanishi Y
Methods Mol Biol; 2019; 1888():189-203. PubMed ID: 30519948
[TBL] [Abstract][Full Text] [Related]
8. Computational probing protein-protein interactions targeting small molecules.
Wang YC; Chen SL; Deng NY; Wang Y
Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
Dutta D; Das R; Mandal C; Mandal C
J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
[TBL] [Abstract][Full Text] [Related]
10. Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors.
Cichonska A; Ravikumar B; Parri E; Timonen S; Pahikkala T; Airola A; Wennerberg K; Rousu J; Aittokallio T
PLoS Comput Biol; 2017 Aug; 13(8):e1005678. PubMed ID: 28787438
[TBL] [Abstract][Full Text] [Related]
11. 3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors.
Gogoi D; Baruah VJ; Chaliha AK; Kakoti BB; Sarma D; Buragohain AK
J Theor Biol; 2016 Dec; 411():68-80. PubMed ID: 27693363
[TBL] [Abstract][Full Text] [Related]
12. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
13. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
[TBL] [Abstract][Full Text] [Related]
14. Machine learning prediction of oncology drug targets based on protein and network properties.
Dezső Z; Ceccarelli M
BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
[TBL] [Abstract][Full Text] [Related]
15. Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures.
Sawada R; Iwata M; Tabei Y; Yamato H; Yamanishi Y
Sci Rep; 2018 Jan; 8(1):156. PubMed ID: 29317676
[TBL] [Abstract][Full Text] [Related]
16. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.
Wang N; Wang L; Xie XQ
J Chem Inf Model; 2017 Nov; 57(11):2686-2698. PubMed ID: 29016123
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome profiling reveals target in primary myelofibrosis together with structural biology study on novel natural inhibitors regarding JAK2.
Li W; Yuan B; Zhao Y; Lu T; Zhang S; Ding Z; Wang D; Zhong S; Gao G; Yan M
Aging (Albany NY); 2021 Mar; 13(6):8248-8275. PubMed ID: 33686952
[TBL] [Abstract][Full Text] [Related]
18. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
19. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling.
Bjij I; Ramharack P; Khan S; Cherqaoui D; Soliman MES
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466292
[TBL] [Abstract][Full Text] [Related]
20. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
